A biomarker, PROSTOX, predicted late genitourinary toxicity accurately in patients with prostate cancer, yielding an area under the curve of 0.76.

This finding reinforces PROSTOX as a true measure of the biological response to radiation, independent of treatment era or technique, that can identify the safest course of [prostate cancer ...

Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small cell lung cancer (NSCLC) and small cell lung ...

(HealthDay News) — A biomarker consisting primarily of microRNA-based germline biomarkers ... toxicity in patients with prostate cancer, according to a study published online April 7 in Clinical ...

Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

An AI-powered blood test for detecting 12 common cancers has been awarded government funding for further clinical trials.

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which ...

A test to identify higher risk of developing urinary side effects after radiation in patients with prostate cancer was ...

A new University of Cincinnati Cancer Center study has identified a particular strand of microRNA as a promising new target for overcoming breast cancer treatment resistance and improving outcomes.

The breakthrough blood test uses AI to detect the 12 most lethal and common cancers from an mRNA signature which shows if ...